Imaging Inflammation in Alzheimer's Disease With 11C-ER176
Status:
Enrolling by invitation
Trial end date:
2022-07-20
Target enrollment:
Participant gender:
Summary
This study is being done to learn about inflammation in the brain of those with Alzheimer's
disease (AD). The purpose of this study is to determine if 11C-ER176 is able to accurately
measure inflammation in patients with Alzheimer's disease. Both patients (with either mild
cognitive impairment (MCI) or Alzheimer's disease) and healthy controls (participants without
memory complaints or impairment) will be included in this study.